Nonalcoholic fatty liver disease (NAFLD) is a major health problem that is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Join endocrine experts Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, and Sangeeta Kashyap MD, Assistant Chief of Clinical Affairs at New York-Presbyterian/Weill Cornell Medical Center, to learn how to diagnose and manage NAFLD and NASH in primary care and endocrinology clinical settings. Key topics include screening for NAFLD/NASH, and the latest management recommendations including supplements, medications, bariatric surgery, and more.